Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

ConditionsParkinsonism or Parkinson's Disease Nos Parkinsonism in Diseases Classified Elsewhere

Trial statusNot yet recruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexAll

Age48-70

SponsorBiocells Medical

About this trial

This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism.

The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Intrathecal (IT)
Intravenous

Treatment groups

120 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Biocells Medical

Lead sponsor

Source ClinicalTrials.gov